HM
Therapeutic Areas
Assertio Holdings Pipeline
| Drug | Indication | Phase |
|---|---|---|
| INDOCIN Suppositories | Patent Ductus Arteriosus (PDA) | Approved |
| INDOCIN Oral | Rheumatoid Arthritis, Osteoarthritis, Gout | Approved |
| Otrexup | Rheumatoid Arthritis, Psoriasis | Approved |
| ROLVEDON | Chemotherapy-induced Neutropenia | Approved |
| SYMJEPI | Anaphylaxis | Approved |
| Pipeline Candidate | Undisclosed | Undisclosed |